Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.
|Poll|August 24, 2020
Poll: Psychiatrists and the 2020 Presidential Election
Author(s)Heidi Anne Duerr, MPH
Do you live by the old adage not to discuss religion or politics? Or, do you welcome controversy and let the chips fall where they may?
Advertisement
Between the Goldwater Rule and boundary issues, it can be tricky for the field and individual psychiatrists to address issues like politics and election anxiety.
How do you handle these discussions in your practice and life?
Advertisement
Related to this article
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5